Portable device detects blood clots

Electrical engineering researchers at the University of Sydney have developed a new technology that could help detect blockages in lung arteries in real time.

The 3-year ARC-funded project investigated an alternative method for diagnosing pulmonary embolism (PE) that combined electrical impedance tomography (EIT) and saline-based contrast solution.

The team was focused on developing a portable, radiation-free and non-toxic device to replace the current invasive procedure that relies heavily on methods such as CT pulmonary angiograms, said PhD candidate Trang Nguyen, an Australian Research Council Postgraduate Award recipient and lead author of the paper published in The Journal of Physiological Measurement.

“This approach exposes a patient to ionising radiation and nephrotoxic contrast agents. It also requires a patient to be moved to a dedicated imaging chamber, which is far from ideal for critically ill patients.

“EIT is an emerging clinical tool. It is a non-invasive medical imaging technique that uses electrical currents to probe impedance changes within the body,” explained Nguyen.

“Ventilation and perfusion are two sides of the same coin. We started from the premise that in order to understand the physiological state of the patient’s lungs, both ventilation and pulmonary perfusion information are required. We were particularly motivated by the possibility of using EIT for diagnosis of PE,” she explained.

With assistance from Westmead Cardiology Research Group, the team concluded that EIT can reliably detect the difference between normal and embolised lungs with a one-sided perfusion defect, pointing out that a larger trial is required before the method can be used clinically for diagnosis of PE.

Pulmonary embolism is a sudden blockage in a lung artery. The blockage usually is caused by a blood clot that travels to the lung from a vein in the leg.

“While PE can lead to severe and possible long-term damage of the cardiovascular system, its symptoms are highly unspecific,” said senior author Dr Alistair McEwan and Nuygen’s PhD supervisor.

“As EIT is less invasive and does not use radiation, we are hopeful that it can be used as a first-stop imaging diagnosis for PE before a CT pulmonary angiogram is prescribed, to reduce radiation and contrast exposure in patients,” said Dr McEwan, who leads a research team dedicated to researching the electrical properties of biological tissue.

“Understanding these properties will enable us to better address a range of major health challenges relating to cardiovascular disease, cancer and nutrition,” he said.